Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has shared an announcement.
On September 11, 2025, MIRA Pharmaceuticals, Inc. held its Annual Meeting of Shareholders where the 2022 Omnibus Incentive Plan was approved. This plan increases the number of shares reserved from 5,000,000 to 8,000,000 and allows for the repricing of options or stock appreciation rights, potentially impacting the company’s financial strategies and shareholder value.
The most recent analyst rating on (MIRA) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on MIRA Pharmaceuticals, Inc. stock, see the MIRA Stock Forecast page.
More about MIRA Pharmaceuticals, Inc.
Average Trading Volume: 1,328,501
Technical Sentiment Signal: Strong Buy
For an in-depth examination of MIRA stock, go to TipRanks’ Overview page.